Treatment with dopamine β-hydroxylase (DBH) inhibitors prevents morphine use and relapse-like behavior in rats.
Małgorzata FrankowskaPaulina SurówkaAgata SuderRenata PieniążekRenata PukłoJoanna JastrzębskaWładysława A DanielMałgorzata FilipMagdalena Zadrożny-BujalskaPatrycja KleczkowskaPublished in: Pharmacological reports : PR (2021)
These results seem to point to the significance of DBH inhibition as a potential pharmacotherapy against morphine use disorders.